{"entity":{"type":"insider","cik":"0001531562","url":"/insider/0001531562","json_url":"/insider/0001531562.json","name":"Sullivan William A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2014-10-01","last":"2018-12-18","span_basis":"filed_date"},"name_variants":[{"name":"Sullivan William A.","source":"filing","n_filings":8,"first_seen":"2014-10-01","last_seen":"2018-12-18"}],"transactions":[{"id":6277800,"accession":"0001273636-18-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001273636-18-000083","line_url":"/filing/0001273636-18-000083#line-1","is_derivative":false,"issuer_cik":"0001273636","issuer_name":"APPLIED GENETIC TECHNOLOGIES CORP","issuer_ticker":"AGTC","issuer_name_source":null,"issuer_url":"/issuer/0001273636","owner_cik":"0001531562","owner_name":"Sullivan William A.","owner_display_name":"Sullivan William A.","owner_url":"/insider/0001531562","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.33,"price_display":"3.33","price_state":"stated","total_value":9990.0,"total_display":"9,990.00","total_whole":"9,990","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-14","filed_date":"2018-12-18","scope":"insider"},{"id":8739197,"accession":"0001179110-15-011301","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-011301","line_url":"/filing/0001179110-15-011301#line-3","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531562","owner_name":"Sullivan William A.","owner_display_name":"Sullivan William A.","owner_url":"/insider/0001531562","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":11.85,"price_display":"11.85","price_state":"stated","total_value":177750.0,"total_display":"177,750.00","total_whole":"177,750","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-15","filed_date":"2015-07-17","scope":"insider"},{"id":8878059,"accession":"0001179110-15-009844","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-009844","line_url":"/filing/0001179110-15-009844#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531562","owner_name":"Sullivan William A.","owner_display_name":"Sullivan William A.","owner_url":"/insider/0001531562","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":10.65,"price_display":"10.65","price_state":"stated","total_value":159750.0,"total_display":"159,750.00","total_whole":"159,750","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-15","scope":"insider"},{"id":8895727,"accession":"0001179110-15-008110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-008110","line_url":"/filing/0001179110-15-008110#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531562","owner_name":"Sullivan William A.","owner_display_name":"Sullivan William A.","owner_url":"/insider/0001531562","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":12.37,"price_display":"12.37","price_state":"stated","total_value":185550.0,"total_display":"185,550.00","total_whole":"185,550","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-15","filed_date":"2015-05-19","scope":"insider"},{"id":8072918,"accession":"0001179110-15-006336","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-006336","line_url":"/filing/0001179110-15-006336#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531562","owner_name":"Sullivan William A.","owner_display_name":"Sullivan William A.","owner_url":"/insider/0001531562","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":12.87,"price_display":"12.87","price_state":"stated","total_value":193050.0,"total_display":"193,050.00","total_whole":"193,050","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-15","filed_date":"2015-04-15","scope":"insider"},{"id":8674629,"accession":"0001179110-15-005303","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-005303","line_url":"/filing/0001179110-15-005303#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531562","owner_name":"Sullivan William A.","owner_display_name":"Sullivan William A.","owner_url":"/insider/0001531562","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":11.97,"price_display":"11.97","price_state":"stated","total_value":179550.0,"total_display":"179,550.00","total_whole":"179,550","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-20","scope":"insider"},{"id":6671479,"accession":"0001179110-14-018741","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-018741","line_url":"/filing/0001179110-14-018741#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531562","owner_name":"Sullivan William A.","owner_display_name":"Sullivan William A.","owner_url":"/insider/0001531562","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":10.7,"price_display":"10.70","price_state":"stated","total_value":160500.0,"total_display":"160,500.00","total_whole":"160,500","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-24","filed_date":"2014-12-29","scope":"insider"},{"id":6368576,"accession":"0001179110-14-014724","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-014724","line_url":"/filing/0001179110-14-014724#line-4","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531562","owner_name":"Sullivan William A.","owner_display_name":"Sullivan William A.","owner_url":"/insider/0001531562","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40878.0,"shares_display":"40,878","price_per_share":8.94,"price_display":"8.94","price_state":"stated","total_value":365449.32,"total_display":"365,449.32","total_whole":"365,449","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-30","filed_date":"2014-10-01","scope":"insider"},{"id":6368571,"accession":"0001179110-14-014724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-014724","line_url":"/filing/0001179110-14-014724#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531562","owner_name":"Sullivan William A.","owner_display_name":"Sullivan William A.","owner_url":"/insider/0001531562","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64404.0,"shares_display":"64,404","price_per_share":8.4,"price_display":"8.40","price_state":"stated","total_value":540993.6,"total_display":"540,993.60","total_whole":"540,994","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-29","filed_date":"2014-10-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001273636","name":"APPLIED GENETIC TECHNOLOGIES CORP","url":"/issuer/0001273636","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2018-12-18","last_seen":"2018-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001274792","name":"MERRIMACK PHARMACEUTICALS INC","url":"/issuer/0001274792","role":"Officer (CFO and Treasurer)","n_filings":7,"first_seen":"2014-10-01","last_seen":"2015-07-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001531562","retrieved_at":"2026-08-23T07:59:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}